Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

Facial Safe Zones for Soft Tissue Filler Injections: A Practical Guide

Freytag DL, Frank K, Haidar R, Rudolph C, Muste J, Schenck TL, Green JB, Lachman N, Bialowas C, Cotofana S.

J Drugs Dermatol. 2019 Sep 1;18(9):896-902.

PMID:
31524345
2.

Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.

Wang A, Green JB, Halperin JL, Piccini JP Sr.

J Am Coll Cardiol. 2019 Aug 27;74(8):1107-1115. doi: 10.1016/j.jacc.2019.07.020. Review.

PMID:
31439220
3.

Lifting vs volumizing-The difference in facial minimally invasive procedures when respecting the line of ligaments.

Casabona G, Frank K, Koban KC, Freytag DL, Schenck TL, Lachman N, Green JB, Toni S, Rudolph C, Cotofana S.

J Cosmet Dermatol. 2019 Aug 12. doi: 10.1111/jocd.13089. [Epub ahead of print]

PMID:
31402563
4.

Molar Bud-to-Cap Transition Is Proliferation Independent.

Yamada S, Lav R, Li J, Tucker AS, Green JBA.

J Dent Res. 2019 Aug 8:22034519869307. doi: 10.1177/0022034519869307. [Epub ahead of print]

PMID:
31393749
5.

Influences of Age, Gender, and Body Mass Index on the Depth of the Superficial Fascia of the Arm and Thigh.

Casabona G, Frank K, Koban KC, Gotkin RH, Webb KL, Freytag DL, Green JB, Nicolau PJ, Schenck TL, Cotofana S.

Dermatol Surg. 2019 Jul 8. doi: 10.1097/DSS.0000000000001986. [Epub ahead of print]

PMID:
31318826
6.

Subperiosteal injections during facial soft tissue filler injections-Is it possible?

Pavicic T, Yankova M, Schenck TL, Frank K, Freytag DL, Sykes J, Green JB, Hamade H, Casabona G, Cotofana S.

J Cosmet Dermatol. 2019 Jul 16. doi: 10.1111/jocd.13073. [Epub ahead of print]

PMID:
31310047
7.

Influence of needle size and injection angle on the distribution pattern of facial soft tissue fillers.

Pavicic T, Mohmand HM, Yankova M, Schenck TL, Frank K, Freytag DL, Green JB, Hamade H, Cassuto D, Cotofana S.

J Cosmet Dermatol. 2019 Jul 8. doi: 10.1111/jocd.13066. [Epub ahead of print]

PMID:
31282607
8.

Relationship between forehead motion and the shape of forehead lines-A 3D skin displacement vector analysis.

Frank K, Freytag DL, Schenck TL, Green JB, Trovato A, Barade H, Rosamilia G, Lachman N, Giunta RE, Cotofana S.

J Cosmet Dermatol. 2019 Jul 8. doi: 10.1111/jocd.13065. [Epub ahead of print]

PMID:
31282119
9.

Clinical Validation of the Surface Volume Coefficient for Minimally Invasive Treatment of the Temple

Cotofana S, Koban K, Pavicic T, Yankonva M, Frank K, Green JB, Gotkin RH, Etzel L, Giunta RE, Schenck TL.

J Drugs Dermatol. 2019 Jun 1;18(6):533.

PMID:
31251545
10.

Influence of Age, Sex, and Body Mass Index on the Thickness of the Gluteal Subcutaneous Fat: Implications for Safe Buttock Augmentation Procedures.

Frank K, Casabona G, Gotkin RH, Kaye KO, Lorenc PZ, Schenck TL, Lachman N, Green JB, Duran-Vega H, Cotofana S.

Plast Reconstr Surg. 2019 Jul;144(1):83-92. doi: 10.1097/PRS.0000000000005707.

PMID:
31246807
11.

Comprehensive Perioperative Management Considerations in Patients Taking Methadone.

Cornett EM, Kline RJ, Robichaux SL, Green JB, Anyama BC, Gennuso SA, Okereke EC, Kaye AD.

Curr Pain Headache Rep. 2019 Jun 17;23(7):49. doi: 10.1007/s11916-019-0783-z. Review.

PMID:
31209656
13.

Preoperative patient preparation in enhanced recovery pathways.

Iqbal U, Green JB, Patel S, Tong Y, Zebrower M, Kaye AD, Urman RD, Eng MR, Cornett EM, Liu H.

J Anaesthesiol Clin Pharmacol. 2019 Apr;35(Suppl 1):S14-S23. doi: 10.4103/joacp.JOACP_54_18. Review.

14.
15.

Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163.

Standl E, Green JB, Holman RR; TECOS Study Group.

Diabetes Care. 2019 Jun;42(6):e95. doi: 10.2337/dc18-2597. No abstract available.

PMID:
31110121
16.
17.

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.

Guimarães PO, Peterson ED, Stevens SR, Lokhnygina Y, Green JB, McGuire DK, Holman RR, Lopes RD.

Int J Cardiol. 2019 Aug 15;289:58-62. doi: 10.1016/j.ijcard.2019.04.085. Epub 2019 Apr 30.

PMID:
31079973
18.

Thoracic Outlet Syndrome: A Comprehensive Review of Pathophysiology, Diagnosis, and Treatment.

Jones MR, Prabhakar A, Viswanath O, Urits I, Green JB, Kendrick JB, Brunk AJ, Eng MR, Orhurhu V, Cornett EM, Kaye AD.

Pain Ther. 2019 Jun;8(1):5-18. doi: 10.1007/s40122-019-0124-2. Epub 2019 Apr 29. Review.

19.

A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat.

Glogau RG, Glaser DA, Callender VD, Yoelin S, Dover JS, Green JB, Breshears L, Bowen B.

Dermatol Surg. 2019 Apr 12. doi: 10.1097/DSS.0000000000001850. [Epub ahead of print]

PMID:
30998531
20.

Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB.

Am J Manag Care. 2019 Apr;25(4):171-172.

21.

The Surface-Volume Coefficient of the Superficial and Deep Facial Fat Compartments: A Cadaveric Three-Dimensional Volumetric Analysis.

Cotofana S, Koban KC, Konstantin F, Green JB, Etzel L, Giunta RE, Schenck TL.

Plast Reconstr Surg. 2019 Jun;143(6):1605-1613. doi: 10.1097/PRS.0000000000005524.

PMID:
30907804
22.

Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).

McGuinn KP, Saedi N, Green JB, Dover JS.

Dermatol Surg. 2019 May;45(5):756-757. doi: 10.1097/DSS.0000000000001910. No abstract available.

PMID:
30893165
23.

An Observational Study of the Safety and Efficacy of Tissue Stabilized-Guided Subcision.

Geronemus RG, Kilmer SL, Wall SH Jr, Green JB, Cohen JL, Weiss RA, Alster TS, Kaminer MS, Gupta A.

Dermatol Surg. 2019 Aug;45(8):1057-1062. doi: 10.1097/DSS.0000000000001911.

PMID:
30893161
24.

Commentary on Effectiveness of Early Laser Treatment in Surgical Scar Minimization.

Green JB.

Dermatol Surg. 2019 Mar 18. doi: 10.1097/DSS.0000000000001928. [Epub ahead of print] No abstract available.

PMID:
30893156
25.

Influence of Age, Sex, and Body Mass Index on the Depth of the Superficial Fascia in the Face and Neck.

Casabona G, Frank K, Koban KC, Schenck TL, Lopez VP, Webb KL, Hamade H, Freytag DL, Green JB, Cotofana S.

Dermatol Surg. 2019 Mar 12. doi: 10.1097/DSS.0000000000001909. [Epub ahead of print]

PMID:
30882511
26.

Progression of glucose-lowering diabetes therapy in TECOS.

Bethel MA, Engel SS, Stevens SR, Lokhnygina Y, Ding J, Josse RG, Alvarsson M, Hramiak I, Green JB, Peterson ED, Holman RR; TECOS Study Group.

Endocrinol Diabetes Metab. 2018 Dec 22;2(1):e00053. doi: 10.1002/edm2.53. eCollection 2019 Jan.

27.

Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.

McHugh K, DeVore AD, Wu J, Matsouaka RA, Fonarow GC, Heidenreich PA, Yancy CW, Green JB, Altman N, Hernandez AF.

J Am Coll Cardiol. 2019 Feb 12;73(5):602-611. doi: 10.1016/j.jacc.2018.11.033. Review.

PMID:
30732715
28.

Structural Gender Dimorphism and the Biomechanics of the Gluteal Subcutaneous Tissue: Implications for the Pathophysiology of Cellulite.

Rudolph C, Hladik C, Hamade H, Frank K, Kaminer MS, Hexsel D, Gotkin RH, Sadick NS, Green JB, Cotofana S.

Plast Reconstr Surg. 2019 Apr;143(4):1077-1086. doi: 10.1097/PRS.0000000000005407.

PMID:
30730492
29.

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials.

Fanaroff AC, Clare R, Pieper KS, Mahaffey KW, Melloni C, Green JB, Alexander JH, Jones WS, Harrison RW, Mehta RH, Povsic TJ, Moreira HG, Al-Khatib SM, Roe MT, Kong DF, Mathews R, Tricoci P, Holman RR, Wallentin L, Held C, Califf RM, Alexander KP, Lopes RD.

Circulation. 2019 Feb 12;139(7):863-873. doi: 10.1161/CIRCULATIONAHA.118.037202.

PMID:
30586739
30.

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Herrington WG, Preiss D, Haynes R, von Eynatten M, Staplin N, Hauske SJ, George JT, Green JB, Landray MJ, Baigent C, Wanner C.

Clin Kidney J. 2018 Dec;11(6):749-761. doi: 10.1093/ckj/sfy090. Epub 2018 Oct 25. Review.

32.
33.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.

Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.

PMID:
30291013
34.

Precision in 3-Dimensional Surface Imaging of the Face: A Handheld Scanner Comparison Performed in a Cadaveric Model.

Koban KC, Cotofana S, Frank K, Green JB, Etzel L, Li Z, Giunta RE, Schenck TL.

Aesthet Surg J. 2019 Mar 14;39(4):NP36-NP44. doi: 10.1093/asj/sjy242.

PMID:
30239592
35.

Preventing Heart Failure in Diabetes: Glycemic Targets or Class Effect?

DeVore AD, Green JB.

JACC Heart Fail. 2018 Oct;6(10):831-832. doi: 10.1016/j.jchf.2018.07.014. Epub 2018 Sep 5. No abstract available.

PMID:
30196074
36.

Self-reported Patient Motivations for Seeking Cosmetic Procedures.

Maisel A, Waldman A, Furlan K, Weil A, Sacotte K, Lazaroff JM, Lin K, Aranzazu D, Avram MM, Bell A, Cartee TV, Cazzaniga A, Chapas A, Crispin MK, Croix JA, DiGiorgio CM, Dover JS, Goldberg DJ, Goldman MP, Green JB, Griffin CL, Haimovic AD, Hausauer AK, Hernandez SL, Hsu S, Ibrahim O, Jones DH, Kaufman J, Kilmer SL, Lee NY, McDaniel DH, Schlessinger J, Tanzi E, Weiss ET, Weiss RA, Wu D, Poon E, Alam M.

JAMA Dermatol. 2018 Oct 1;154(10):1167-1174. doi: 10.1001/jamadermatol.2018.2357.

37.

The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.

McHugh KR, DeVore AD, Mentz RJ, Edmonston D, Green JB, Hernandez AF.

Clin Cardiol. 2018 Sep;41(9):1259-1267. doi: 10.1002/clc.23054. Epub 2018 Sep 21. Review.

38.

Highlights of Skin Disease Education Foundations 42nd Annual Hawaii Dermatology Seminar.

Baldwin HE, Stein Gold LF, Gordon KB, Green JB, Leonardi CL, Sengelmann RD.

Semin Cutan Med Surg. 2018 Jun;37(4S):S75-S84. doi: 10.12788/j.sder.2018.031.

PMID:
30016379
39.

Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics.

Green JB, Hernandez AF, D'Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV.

Am Heart J. 2018 Sep;203:30-38. doi: 10.1016/j.ahj.2018.03.030. Epub 2018 Jun 12.

PMID:
30015066
40.

Intestinal β-carotene bioconversion in humans is determined by a new single-sample, plasma isotope ratio method and compared with traditional and modified area-under-the-curve methods.

Ford JL, Green MH, Green JB, Oxley A, Lietz G.

Arch Biochem Biophys. 2018 Sep 1;653:121-126. doi: 10.1016/j.abb.2018.06.015. Epub 2018 Jun 27.

41.

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.

Alfredsson J, Green JB, Stevens SR, Reed SD, Armstrong PW, Angelyn Bethel M, Engel SS, McGuire DK, Van de Werf F, Hramiak I, White HD, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Obes Metab. 2018 Oct;20(10):2379-2388. doi: 10.1111/dom.13377. Epub 2018 Jun 19.

PMID:
29923323
42.

Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB.

Am J Manag Care. 2018 Apr;24(8 Suppl):S146-S155.

43.

Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB.

Am J Manag Care. 2018 Apr;24(8 Suppl):S138-S145.

44.

Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Reed SD, Li Y, Leal J, Radican L, Adler AI, Alfredsson J, Buse JB, Green JB, Kaufman KD, Riefflin A, Van de Werf F, Peterson ED, Gray AM, Holman RR; TECOS Study Group.

Diabetes Obes Metab. 2018 Jul;20(7):1732-1739. doi: 10.1111/dom.13292. Epub 2018 Apr 20.

PMID:
29573215
45.

Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain.

Ehrhardt KP Jr, Mothersele SM, Brunk AJ, Green JB, Jones MR, Billeaud CB, Kaye AD.

Curr Pain Headache Rep. 2018 Mar 19;22(4):26. doi: 10.1007/s11916-018-0680-x. Review.

PMID:
29556832
46.

The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns.

Keaney TC, Anolik R, Braz A, Eidelman M, Eviatar JA, Green JB, Jones DH, Narurkar VA, Rossi AM, Gallagher CJ.

J Drugs Dermatol. 2018 Jan 1;17(1):19-28. Review.

PMID:
29320584
47.

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.

Standl E, Stevens SR, Armstrong PW, Buse JB, Chan JCN, Green JB, Lachin JM, Scheen A, Travert F, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2018 Mar;41(3):596-603. doi: 10.2337/dc17-1778. Epub 2018 Jan 8.

PMID:
29311155
48.

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.

Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, Green JB, Buse JB, Inzucchi SE, Leiter LA, Raz I, Rosenstock J, Riddle MC.

Diabetes Care. 2018 Jan;41(1):14-31. doi: 10.2337/dci17-0057.

49.

Combined aesthetic interventions for prevention of facial ageing, and restoration and beautification of face and body.

Fabi S, Pavicic T, Braz A, Green JB, Seo K, van Loghem JA.

Clin Cosmet Investig Dermatol. 2017 Oct 30;10:423-429. doi: 10.2147/CCID.S144282. eCollection 2017.

50.

Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive Behaviors.

Rossi AM, Eviatar J, Green JB, Anolik R, Eidelman M, Keaney TC, Narurkar V, Jones D, Kolodziejczyk J, Drinkwater A, Gallagher CJ.

Dermatol Surg. 2017 Nov;43 Suppl 2:S210-S220. doi: 10.1097/DSS.0000000000001293.

PMID:
29064988

Supplemental Content

Loading ...
Support Center